Jan 26, 2018
Durham-based Biomarck Pharmaceuticals, a portfolio company of the North Carolina Biotechnology Center, has launched a Phase 2 clinical trial of a potential therapy for treating advanced non-small cell lung cancer (NSCLC).…
May 26, 2017
A new drug, discovered and developed in the Triangle, shows promise in treating cancer. It’s a story CBS North Carolina first reported on last year. At the time, the drug…
Apr 24, 2017
North Carolina based Biomarck Pharmaceuticals, Inc. has received FDA allowance l to begin human trials for their patented compound BIO-11006, for adults with lung cancer. Discovered by Dr. Ken Adler…
Jan 24, 2017
Thursday’s episode of UNC-TV’s “NC Now,” included a segment titled “Aspirin of the Future,” about the development of a drug by Adler, a professor of cell biology at the North…